Free lookups: 0/3 Unlock Pro
Clinical reference Find a medicine
Ctrl K
0 of 3 free lookups remaining Upgrade
New search Medicine profile Benzathine Penicillin

Clinical medicine profile

Benzathine Penicillin

Beta-lactam antibiotic — penicillin

POM
Evidence state Source not available Reviewed 14 Aug 2026
Route
ORAL / PARENTERAL (agent-dependent)
Schedule
POM
ATC
Not assigned
PPB status
registered
Patient advice Check interactions
Verification required

This profile needs source confirmation

A traceable source link is not attached to this profile. Confirm prescribing decisions against the current SmPC and Kenya STG/EML.

01 Risk first

Safety essentials

The information most likely to change a prescribing or dispensing decision.

Contraindications

  • History of serious immediate hypersensitivity (e.g. anaphylaxis, angioedema, urticaria) to any penicillin.
  • Caution with prior severe cephalosporin reaction (cross-reactivity risk).
  • Avoid in infectious mononucleosis if using aminopenicillins (rash risk).

Precautions

  • For deep IM administration only
  • do not administer IV, SC, or IT.
  • Inadvertent IV administration associated with cardiorespiratory arrest and death.
  • Do not inject near nerve or artery.
02 Point of care

Dosing matrix

Population and organ-function guidance, shown together for faster comparison.

Adult

Streptococcal [Group A] upper respiratory infections [e.g, pharyngitis]: Adults: a single injec- tion of 1,200,000 units; older children: a single injection of 900,000 units; infants and children: 300,000 to 600,000 units. Syphilis [less than 1 yr]: 2.4 m.u weekly for 2 weeks. Syphilis [more than 1 yr]: 4 m.u weekly for 4-5 weeks. Yaws, bejel, and pinta: 1,200,000 units [1 injection]. Prophylaxis for rheumatic fever and glomerulonephritis following an acute attack: Penicillin G Benzathine [parenteral] may be given in doses of 1,200,000 units once a month or 600,000 units every 2 weeks.

Paediatric

See label paediatric section if present; otherwise use paediatric formulary — do not extrapolate adult doses.

Renal

Renal excretion dominant — reduce dose or extend interval in significant renal impairment; risk of accumulation and seizures at high levels.

  • CrCl 0–120: Confirm renal dosing in product SmPC / primary label.
Hepatic

Low intrinsic hepatotoxicity; cholestatic hepatitis rare (notably flucloxacillin/co-amoxiclav patterns for related agents).

03 Clinical use

Use, effects & interactions

Indications

  • Therapeutic use is agent- and indication-specific within the class (Beta-lactam antibiotic — penicillin).
  • Use according to culture results, national guidelines (Kenya STG/EML where applicable) and the current product SmPC.
  • See under the dosage

Adverse effects

  • Common: gastrointestinal upset, diarrhoea, mild rash.
  • Serious: anaphylaxis, Stevens–Johnson syndrome / TEN (rare), antibiotic-associated colitis (including C. difficile), interstitial nephritis, haematological reactions with prolonged high dose.
  • For professionals: select agent by suspected pathogen and local resistance.
  • Natural penicillins remain first-line for many streptococcal infections when susceptibility expected.
  • Do not use penicillin alone for beta-lactamase-producing staphylococci.
  • Document allergy phenotype (immediate vs delayed).
  • De-escalate once cultures allow.
04 Pharmacology

Mechanism & disposition

terferes with the synthesis of peptidoglycans, which are part of bacterial cell wall [bactericidal].

Bind PBPsBlock wall cross-linkingOsmotic lysisBactericidal
Read complete mechanism

terferes with the synthesis of peptidoglycans, which are part of bacterial cell wall [bactericidal]. It is the most appropriate drug when prolonged low levels of benzylpenicillin are needed. It has a prolonged antibiotic action (2 - 4 wks after a STAT IM dose).

Onset

Within 1 hour (oral); faster IV

Duration

4–8 hours typical (agent/formulation dependent)

Route

ORAL / PARENTERAL (agent-dependent)

Elimination

is predominantly renal (glomerular filtration and tubular secretion). Dose adjustment is often required in severe renal impairment. Probenecid reduces tubular secretion and prolongs levels.

Half-life

differ by agent and salt/ester. Most penicillins distribute widely into extracellular fluid; CSF penetration is poor unless meninges are inflamed.

05 Special populations

Pregnancy, lactation & diet

Pregnancy

Penicillins are generally considered compatible in pregnancy when clearly indicated (decades of clinical use). Prefer agents with the best safety record for the indication; confirm current SmPC.

Lactation

Usually compatible with breastfeeding; small amounts excreted in milk. Monitor infant for diarrhoea, thrush or rash.

06 Kenya market

Brands & loaded prices

FromKES 321
MedianKES 321
Listings1
BrandManufacturerPackObserved price
CAREBENZAR Not recorded 2.4MEGA VIAL 10*S KES 321.43Daima Chemist price-list reference ↗ Source date not recorded · verify current price
07 Provenance

Sources & review state

Primary sourceLocal active-ingredient clinical extract; Professional class pharmacology (Beta-lactam antibiotic — penicillin)
Last reviewed14 Aug 2026
EvidenceSource not available

Decision support only. Confirm patient-specific decisions against the current product SmPC, Kenya STG/EML, and professional judgement.